✦ LIBER ✦

A multi-cycle open label study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

✍ Scribed by P. Minic; S. Fustic; E. Solyom; H. Mazurek; Y. Antipkin; A. Feketova; A. Senatorova; E. Csiszer; V. Kostromina; B. Takac; R. Ujhelyi; R. Gupta

Book ID: 118642676
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 53 KB
Volume: 9
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(10)60237-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

217* A multi-cycle open label study of n

217* A multi-cycle open label study of nebulized liposomal amikacin (Arikace(tm)) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

✍ P. Minic; S. Fustik; E. Solyom; H. Mazurek; Y. Antipkin; A. Feketeova; A. Senato 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A randomized placebo-controlled study of

A randomized placebo-controlled study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

✍ L. Dupont; P. Minic; S. Fustic; H. Mazurek; E. Solyom; A. Feketova; E. Csiszer; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

48* Nebulized SLIT™ Amikacin in the trea

48* Nebulized SLIT™ Amikacin in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection in Serbia and Hungary

✍ C. Mackinson; P. Minic; A. Sovtic; A. Forrest; R. Gupta 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

WS5.5 A randomised, open label phase 3 s

WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection

✍ M. Goldman; A. Schuster; C. Halliburn; G. Döring 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB